A detailed history of Front Row Advisors LLC transactions in Amedisys Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 27 shares of AMED stock, worth $2,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$2,630
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$92.15 - $95.24 $2,488 - $2,571
27 New
27 $2,000
Q1 2023

May 22, 2023

BUY
$69.79 - $100.33 $1,744 - $2,508
25 Added 1250.0%
27 $2,000
Q1 2023

May 15, 2023

SELL
$69.79 - $100.33 $1,744 - $2,508
-25 Reduced 92.59%
2 $3,000
Q1 2020

May 08, 2020

SELL
$137.21 - $202.02 $1,372 - $2,020
-10 Reduced 27.03%
27 $5,000
Q4 2017

Feb 01, 2018

BUY
$46.45 - $58.49 $1,718 - $2,164
37
37 $2,000

Others Institutions Holding AMED

About AMEDISYS INC


  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $3.17B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.